126 related articles for article (PubMed ID: 38837163)
1. Label Accuracy of Legal Oral Cannabis Oil Products in Ontario, Canada.
Doggett A; Fein A; Campbell T; Henriquez N; Busse JW; MacKillop J
JAMA Netw Open; 2024 Jun; 7(6):e2414922. PubMed ID: 38837163
[TBL] [Abstract][Full Text] [Related]
2. Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners.
Miller OS; Elder EJ; Jones KJ; Gidal BE
Epilepsy Behav; 2022 Feb; 127():108514. PubMed ID: 34998268
[TBL] [Abstract][Full Text] [Related]
3. Cannabis labelling and consumer understanding of THC levels and serving sizes.
Leos-Toro C; Fong GT; Meyer SB; Hammond D
Drug Alcohol Depend; 2020 Mar; 208():107843. PubMed ID: 32044091
[TBL] [Abstract][Full Text] [Related]
4. An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina.
Fernández N; Cappello MG; Quiroga PN
Forensic Sci Int; 2023 Aug; 349():111762. PubMed ID: 37392612
[TBL] [Abstract][Full Text] [Related]
5. Warning Labels as a Public Health Intervention: Effects and Challenges for Tobacco, Cannabis, and Opioid Medications.
Popova L; Massey ZB; Giordano NA
Annu Rev Public Health; 2024 May; 45(1):425-442. PubMed ID: 38166502
[TBL] [Abstract][Full Text] [Related]
6. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.
Hammond D; Goodman S
Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866
[No Abstract] [Full Text] [Related]
7. Content versus Label Claims in Cannabidiol (CBD)-Containing Products Obtained from Commercial Outlets in the State of Mississippi.
Gurley BJ; Murphy TP; Gul W; Walker LA; ElSohly M
J Diet Suppl; 2020; 17(5):599-607. PubMed ID: 32431186
[TBL] [Abstract][Full Text] [Related]
8. Noticing of cannabis health warning labels in Canada and the US.
Goodman S; Hammond D
Health Promot Chronic Dis Prev Can; 2021; 41(7-8):201-210. PubMed ID: 34427418
[TBL] [Abstract][Full Text] [Related]
9. The impact of plain packaging and health warnings on consumer appeal of cannabis products.
Goodman S; Leos-Toro C; Hammond D
Drug Alcohol Depend; 2019 Dec; 205():107633. PubMed ID: 31678837
[TBL] [Abstract][Full Text] [Related]
10. Heating of consumer cannabis oils can lead to free radical initiated degradation, causing CBD and THC depletion.
Tonoyan L; Babu D; Reiz B; Le T; Siraki AG
Free Radic Biol Med; 2022 Nov; 192():77-83. PubMed ID: 36113706
[TBL] [Abstract][Full Text] [Related]
11. Regulating Cannabis Manufacturing: Applying Public Health Best Practices from Tobacco Control.
Orenstein DG; Glantz SA
J Psychoactive Drugs; 2018; 50(1):19-32. PubMed ID: 29438634
[TBL] [Abstract][Full Text] [Related]
12. Perceptions of cannabis health information labels among people who use cannabis in the U.S. and Canada.
Winstock AR; Lynskey MT; Maier LJ; Ferris JA; Davies EL
Int J Drug Policy; 2021 May; 91():102789. PubMed ID: 32499118
[TBL] [Abstract][Full Text] [Related]
13. Trends in the use of cannabis products in Canada and the USA, 2018 - 2020: Findings from the International Cannabis Policy Study.
Hammond D; Goodman S; Wadsworth E; Freeman TP; Kilmer B; Schauer G; Pacula RL; Hall W
Int J Drug Policy; 2022 Jul; 105():103716. PubMed ID: 35613480
[TBL] [Abstract][Full Text] [Related]
14. Requirements for Cannabis Product Labeling by U.S. State.
Kruger DJ; Korach NJ; Kruger JS
Cannabis Cannabinoid Res; 2022 Apr; 7(2):156-160. PubMed ID: 33998880
[No Abstract] [Full Text] [Related]
15. Drafting warnings for medical products: practical considerations for minimizing litigation.
Dunne KJ; Patterson KD; Baroumand CR
Healthspan; 1993 Sep; 10(8):11-20. PubMed ID: 10129147
[No Abstract] [Full Text] [Related]
16. Use and Perceptions of Cannabidiol Products in Canada and in the United States.
Goodman S; Wadsworth E; Schauer G; Hammond D
Cannabis Cannabinoid Res; 2022 Jun; 7(3):355-364. PubMed ID: 33998872
[No Abstract] [Full Text] [Related]
17. Availability, retail price and potency of legal and illegal cannabis in Canada after recreational cannabis legalisation.
Mahamad S; Wadsworth E; Rynard V; Goodman S; Hammond D
Drug Alcohol Rev; 2020 May; 39(4):337-346. PubMed ID: 32291811
[TBL] [Abstract][Full Text] [Related]
18. Use of Symbols in Labeling. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2016 Jun; 81(115):38911-31. PubMed ID: 27311137
[TBL] [Abstract][Full Text] [Related]
19. Selling cannabidiol products in Canada: A framing analysis of advertising claims by online retailers.
Zenone MA; Snyder J; Crooks V
BMC Public Health; 2021 Jul; 21(1):1285. PubMed ID: 34210299
[TBL] [Abstract][Full Text] [Related]
20. Commercial cannabis consumer products part 2: HPLC-DAD quantitative analysis of cannabis cannabinoids.
Ciolino LA; Ranieri TL; Taylor AM
Forensic Sci Int; 2018 Aug; 289():438-447. PubMed ID: 30025568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
